OM
Opaleye Management’s Sutro Biopharma STRO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-301,491
| Closed | -$1.29M | – | 58 |
|
2023
Q4 | $1.29M | Buy |
+301,491
| New | +$1.29M | 0.34% | 42 |
|
2023
Q3 | – | Sell |
-307,000
| Closed | -$1.43M | – | 50 |
|
2023
Q2 | $1.43M | Buy |
+307,000
| New | +$1.43M | 0.34% | 38 |
|
2022
Q2 | – | Sell |
-89,980
| Closed | -$740K | – | 54 |
|
2022
Q1 | $740K | Sell |
89,980
-590,020
| -87% | -$4.85M | 0.23% | 43 |
|
2021
Q4 | $10.1M | Buy |
680,000
+142,200
| +26% | +$2.12M | 2.15% | 16 |
|
2021
Q3 | $10.2M | Buy |
537,800
+40,900
| +8% | +$773K | 1.9% | 16 |
|
2021
Q2 | $9.24M | Buy |
496,900
+154,950
| +45% | +$2.88M | 1.53% | 22 |
|
2021
Q1 | $7.78M | Buy |
341,950
+19,750
| +6% | +$450K | 1.14% | 27 |
|
2020
Q4 | $7M | Buy |
322,200
+176,200
| +121% | +$3.83M | 0.91% | 29 |
|
2020
Q3 | $1.47M | Buy |
+146,000
| New | +$1.47M | 0.29% | 46 |
|